In addition, FCRLA has been shown to participate in immune response‐related pathways in various malignancies, including advanced laryngeal cancer, hepatocellular carcinoma, and ovarian cancer, hepatocellular carcinoma and ovarian cancer.17, 18, 19. The gene discussed is FCRLA; the disease is hepatocellular carcinoma.